Antagonism of chemokine receptor CCR8 is ineffective in a primate model of asthma

Thorax

Volumn 68, Issue 6, 2013, Pages 506-512

  Wang, Lin ^a,b   Jenkins, Tracy J ^a,c   Dai, Mingshi ^a,d   Yin, Wei ^a,e   Pulido, Jacqueline C ^a,f   Lamantia Martin, Elise ^g   Hodge, Martin R ^a,h   Ocain, Timothy ^a,i   Kolbeck, Roland ^a,j  

^a MILLENNIUM PHARMACEUTICALS INC   (United States)

^b GLAXOSMITHKLINE   (United States)

^c BIOGEN   (United States)

^d World Financial Group Inc   (United States)

^e AVEO ONCOLOGY   (United States)

^f Aveo Oncology ^*

^g CHARLES RIVER LABORATORIES   (United States)

^h PFIZER INC   (United States)

ⁱ Seaside Therapeutics   (United States)

^j MEDIMMUNE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR ANTAGONIST; CHEMOKINE RECEPTOR CCR8; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; ML 604086; UNCLASSIFIED DRUG;

AIRWAY RESISTANCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; BINDING AFFINITY; BINDING SITE; CONTINUOUS INFUSION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA SEQUENCE; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG PROTEIN BINDING; EOSINOPHILIA; LOADING DRUG DOSE; LUNG FUNCTION; LUNG LAVAGE; MACACA FASCICULARIS; MUCUS SECRETION; NONHUMAN; NUCLEOTIDE SEQUENCE; PNEUMONIA; PRIORITY JOURNAL; PROVOCATION TEST; RESPIRATORY TRACT ALLERGY; SEQUENCE ANALYSIS; TH2 CELL;

EID: 84877595656     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2012-203012     Document Type: Article

References (39)

1. Wardlaw AJ, Brightling CE, Green R, et al. New insights into the relationship between airway inflammation and asthma. Clin Sci (London) 2002;103:201-11.
2. Calhoun WJ, Sedgwick J, Busse WW. The role of eosinophils in the pathophysiology of asthma. Ann N Y Acad Sci 1991;629:62-72.
3. Brightling CE, Bradding P, Symon FA, et al. Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med 2002;346:1699-705. (Pubitemid 34547483)
4. Robinson DS, Hamid Q, Ying S, et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992;326:298-304.
5. Taylor IK, O'Shaughnessy KM, Fuller RW, et al. Effect of cysteinyl leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects. Lancet 1991;337:690-4.
6. Twentyman OP, Oilier S, Holgate ST. The effect of H1-receptor blockade on the development of early-and late-phase bronchoconstriction and increased bronchial responsiveness in allergen-induced asthma. J Allergy Clin Immunol 1993;91:1169-78. (Pubitemid 23173185)
7. Gordon JR, Galli SJ. Mast cells as a source of both preformed and immunologically inducible TNF-a/cachectin. Nature 1990;346:274-6.
8. Bradding P, Feather IH, Howarth PH, et al. Interleukin 4 is localized to and released by human mast cells. J Exp Med 1992;176:1381-6.
9. Kobayashi H, Okayama Y, Ishizuka T, et al. Production of IL-13 by human lung mast cells in response to Fcepsilon receptor cross-linkage. Clin Exp Allergy 1998;28:1219-27. (Pubitemid 29087012)
10. Gilchrest H, Cheewatrakoolpong B, Billah M, et al. Human cord blood-derived mast cells synthesize and release I-309 in response to IgE. Life Sci 2003;73:2571-81. (Pubitemid 37088207)
11. Pilette C, Francis JN, Till SJ, et al. CCR4 ligands are up-regulated in the airways of atopic asthmatics after segmental allergen challenge. Eur Respir J 2004;23:876-84. (Pubitemid 38807362)
12. Sallusto F, Mackay CR, Lanzavecchia A. The role of chemokine receptors in primary, effector, and memory immune responses. Annu Rev Immunol 2000;18:593-620. (Pubitemid 30365392)
13. Sallusto F, Mackay CR, Lanzavecchia A. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 1997;277:2005-7. (Pubitemid 27449145)
14. D'Ambrosio D, Iellem A, Bonecchi R, et al. Selective up-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells. J Immunol 1998;161:5111-15. (Pubitemid 28519063)
15. Soler D, Chapman TR, Poisson LR, et al. CCR8 Expression identifies CD4 memory T cells enriched for FOXP3 regulatory and Th2 effector lymphocytes. J Immunol 2006;177:6940-51. (Pubitemid 44715060)
16. Panina-Bordignon P, D'Ambrosio D. Chemokines and their receptors in asthma and chronic obstructive pulmonary disease. Curr Opin Pulm Med 2003;9:104-10. (Pubitemid 36184560)
17. Gonzalo JA, Qiu Y, Lora JM, et al. Coordinated Involvement of Mast Cells and T Cells in Allergic Mucosal Inflammation: critical role of the CC Chemokine Ligand 1: CCR8. Axis J Immunol 2007;179:1740-50.
18. Chung CD, Kuo F, Kumer J, et al. CCR8 is not essential for the development of inflammation in a mouse model of allergic airway disease. J Immunol 2003;170:581-7. (Pubitemid 36026186)
19. Goya I, Villares R, Zaballos A, et al. Absence of CCR8 does not impair the response to ovalbumin-induced allergic airway disease. J Immunol 2003;170:2138-46. (Pubitemid 36197437)
20. Mikhak Z, Fukui M, Farsidjani A, et al. Contribution of CCR4 and CCR8 to antigen-specific TH2 cell trafficking in allergic pulmonary inflammation. J Allergy Clin Immunol 2009;123:67-73.
21. Montes-Vizuet R, Vega-Miranda A, Valencia-Maqueda E, et al. CC chemokine ligand 1 is released into the airways of atopic asthmatics. Eur Respir J 2006;28:59-67. (Pubitemid 44914261)
22. Mutalithas K, Guillen C, Raport C, et al. Expression of CCR8 is increased in asthma. Clin Exp Allergy 2010;40:1175-85.
23. Islam SA, Chang DS, Colvin RA, et al. Mouse CCL8, a CCR8 agonist, promotes atopic dermatitis by recruiting IL-5+ T (H) 2 cells. Nat Immunol 2011;12:167-77.
24. Jenkins TJ, Guan B, Dai M, et al. Design, synthesis, and evaluation of naphthalene-sulfonamide antagonists of human CCR8. J Med Chem 2007;50:566-84. (Pubitemid 46239790)
25. Pease JE. Is there a role for CCR8 in the pathogenesis of asthma? Clin Exp Allergy 2010;40:1110-12.
26. Coffman RL, Hessel EM. Nonhuman primate models of asthma. J Exp Med 2005;201:1875-9. (Pubitemid 41002922)
27. Piper E, Brightling C, Niven R, et al. A phase 2 placebo-controlled study of tralokinumab in moderate-to-severe asthma. Eur Respir J 2013;41:330-8.
28. Corren J, Lemanske RF, Hanania NA, et al. Lebrikizumab treatment in adults with asthma. N Engl J Med 2011;365:1088-98.
29. Haldar P, Brightling CE, Hargadon B, et al. Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med 2009;360:973-84.
30. Nair P, Pizzichini MM, Kjarsgaard M, et al. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N Engl J Med 2009;360:985-93.
31. Castro M, Mathur S, Hargreave F, et al. Reslizumab for poorly controlled, eosinophilic asthma: a randomized, placebo-controlled study. Am J Respir Crit Care Med 2011;184:1125-32.
32. Mauser PJ, Pitman A, Witt A, et al. Inhibitory effect of the TRFK-5 anti-IL-5 antibody in a guinea pig model of asthma. Am J Respir Crit Care Med 1995;152:467-72.
33. Bree A, Schlerman FJ, Wadanoli M, et al. IL-13 blockade reduces lung inflammation after Ascaris suum challenge in cynomolgus monkeys. J Allergy Clin Immunol 2007;119:1251-7. (Pubitemid 46654187)
34. May RD, Monk PD, Cohen ES, et al. Preclinical development of CAT-354, an IL-13 neutralizing antibody, for the treatment of severe uncontrolled asthma. Br J Pharmacol 2012;166:177-93.
35. Turner CR, Andresen CJ, Smith WB, et al. Characterization of a primate model of asthma using anti-allergy/anti-asthma agents. Inflamm Res 1996;45:239-45.
36. Mellado M, Martín de Ana A, Gómez L, et al. Chemokine receptor 2 blockade prevents asthma in a cynomolgus monkey model. J Pharmacol Exp Ther 2008;324:769-75. (Pubitemid 351185858)
37. Miller LA, Hurst SD, Coffman RL, et al. Airway generation-specific differences in the spatial distribution of immune cells and cytokines in allergen-challenged rhesus monkeys. Clin Exp Allergy 2005;35:894-906. (Pubitemid 41032538)
38. Perros F, Hoogsteden HC, Coyle AJ, et al. Blockade of CCR4 in a humanized model of asthma reveals a critical role for DC-derived CCL17 and CCL22 in attracting Th2 cells and inducing airway inflammation. Allergy 2009;64:995-1002.
39. Hershey GK. IL-13 receptors and signaling pathways: an evolving web. J Allergy Clin Immunol 2003;111:677-90. (Pubitemid 36470232)